Raymond James Financial’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
Raymond James Financial's COGT Position: Q3 2026 in Review
Raymond James Financial reduced its Cogent Biosciences (COGT) stake by 22% in Q3 2026, selling an estimated $5.36M and leaving 528,550 shares worth $16.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1674.
Raymond James Financial first reported a position in COGT in Q2 2025 and has held it in 6 quarters since. The position peaked at $26.1M in Q2 2026. 202 funds tracked by Wall St. Rank hold COGT as of Q3 2026.
- Raymond James Financial held 528,550 shares of Cogent Biosciences worth $16.9M as of Q3 2026.
- Raymond James Financial sold 145,126 Cogent Biosciences shares in Q3 2026, an estimated $5.36M.
- Cogent Biosciences made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #1674 holding.
- Raymond James Financial first reported a position in Cogent Biosciences in Q2 2025 and has held it in 6 quarters since.
- Raymond James Financial's Cogent Biosciences position peaked at $26.1M in Q2 2026.
- 202 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.